#451: A new biomarker for depression? Ben Finlay

This week, James is joined by Ben Finlay, Partner at Stratt and Advisor to Ranvier.ai, to dig into why mental health is still diagnosed by questionnaire - and what a taste test, a blood biomarker and a continuum view of neurological wellness could change. Ben shares the science behind Ranvier's objective mood measurement, the journey from early intervention in depression through to staving off Alzheimer's and Parkinson's, and a candid look at where pharma, policy and AI are heading next.

Connect with Ben: https://www.linkedin.com/in/benfinlay/

Learn more: https://www.ranvier.ai/

Apply to be a guest: www.thehealthtechpodcast.com

Subscribe to Healthtech Pigeon 🐦: www.healthtechpigeon.com

Get in touch with James: www.jamessomauroo.com

This podcast was brought to you by SomX.